European Equity Benchmarks Close Sharply Lower; Juncker Rebukes UK Brexit Papers

European Equity Benchmarks Close Sharply Lower; Juncker Rebukes UK Brexit Papers

The broad-based major European indices closed sharply lower in Tuesday’s trading session, as media companies and banks weighed on markets. In economic news, European Commission President Jean-Claude Juncker expressed his disappointment with the U.K. government’s Brexit position papers in a speech in Brussels today. “I have read with the requisite attention all the papers uttered, produced by Her Majesty’s Government,” said said Juncker. “None really gives me satisfaction, so there […]

Read More ˃
Persimmon Earnings Rise

Persimmon Earnings Rise

Persimmon, a UK homebuilder, said first-half earnings grew amid higher revenues that came as completions increased and average selling prices advanced. Total sales climbed 12% to GBP1.66 billion ($2.1 billion) during the six months that ended June 30, according to the company. Persimmon’s underlying earnings per share rose to 117.1 pence from 90.4 pence a year earlier. Market conditions were stronger than expected last year after the decision made in […]

Read More ˃
Chicago Bridge & Iron Wins Project in Saudi Arabia

Chicago Bridge & Iron Wins Project in Saudi Arabia

Chicago Bridge & Iron Company N.V, which provides services to customers in the energy infrastructure market, has been awarded a contract by Tecnicas Reunidas, S.A. for new product storage tanks at Saudi Aramco’s refinery in Ras Tanura, Saudi Arabia. Financial terms of the deal were not disclosed. CB&I said its scope includes the engineering, procurement, fabrication and construction of nine flat bottom tanks, as well as modifications to numerous existing […]

Read More ˃
Mallinckrodt Acquires InfaCare Pharmaceutical

Mallinckrodt Acquires InfaCare Pharmaceutical

Mallinckrodt shares were down 1.6% pre-market Friday after the specialty pharmaceutical firm said it has agreed to acquire InfaCare Pharmaceutical, a privately held specialty pharmaceutical company focused on development and commercialization of proprietary pharmaceuticals for neonatal and pediatric patient populations. Financial terms of the transaction include an upfront payment of $80 million, with additional payments of up to $345 million dependent on regulatory and sales milestones. Mallinckrodt said expects the […]

Read More ˃
MiMedx Group Shares Rise

MiMedx Group Shares Rise

MiMedx Group, Inc reported Q2 EPS of $0.07, versus $0.05 last year. This was in-line with Capital IQ estimates. Revenue for the quarter came in at $76.4 million, versus $57.3 million last year and ahead of the $74.2 million Capital IQ estimate. The company said it sees Q3 revenue in the range of $79 million to $80 million. The Street is at $76.2 million. For the full year, the company […]

Read More ˃